期刊文献+

非酒精性脂肪肝患者血清视黄醛结合蛋白4及其相关因素分析 被引量:1

下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)是一种肝组织病理学改变,与酒精性肝病类似但无过量饮酒史的临床综合征。NAFLD疾病谱主要包括单纯性脂肪肝、脂肪性肝炎、脂肪性肝硬化3种主要类型。目前认为脂代谢异常、高胰岛素血症是NAFLD发病机制的中心环节。视黄醛结合蛋白(RBP)4是新近发现的一种与胰岛素抵抗相关的脂肪因子,血清RBP4在肥胖、胰岛素抵抗的动物模型和肥胖人群中升高2~13倍左右,RBP4抑制胰岛素在肌肉组织的受体后信号传导过程,它是脂肪组织储存空间不足的一种“异常”信号.由此加重全身胰岛素抵抗状态,进而导致2型糖尿病。本研究通过测定非糖尿病的NAFLD患者体内RBP4水平,探讨两者之间的关系。
出处 《中国药物与临床》 CAS 2009年第2期142-143,共2页 Chinese Remedies & Clinics
  • 相关文献

参考文献5

  • 1Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis,2004,8:575- 594.
  • 2Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistanse in obesity and type 2 diabetes. Nature, 2005,436: 356-362.
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 4Day CP,James OFW. Steatohepatitis: a talc of two hits. Gastroenterplogy, 1998,114: 842-849.
  • 5Graham TE,Yang Q, Bluher M,et al. Retinol-binding protein 4 and insulin resistance in lean,obese,and diabetic subjects. N Engl J Med, 2006,354: 2552-2563.

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1512

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部